首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
Treatment of her2-positive cancer with paclitaxel and trastuzumab-mcc-dm1
摘要
<p>The present invention relates to combination therapy with paclitaxel, trastuzumab-MCC-DM1 and optionally, pertuzumab.</p>
申请公布号
IL226446(D0)
申请公布日期
2013.07.31
申请号
IL20130226446
申请日期
2013.05.20
申请人
GENENTECH INC.
发明人
分类号
A61K
主分类号
A61K
代理机构
代理人
主权项
地址
您可能感兴趣的专利
SPHERICAL YOLK-SHELL NANOPARTICLES WITH A SILICA SHELL AND SINGLE AU NANODOTS AS THE CORE AND SYNTHETIC METHOD THEROF
DIRECT BONDING METHOD OF PANNEL
ACTUATOR MODULE
DISPENSER VESSEL WITH A STRUCTURE OF PREVENTING LIQUID LEAKAGE
METHOD FOR SWITCHING 3-DIMENSION PAGE SCREEN BY ROUND SHAPE TOUCH INPUT
THE CONTAINER CONTROLLING THE QUANTITY OF ITS CONTENT
STEEL REINFORCED CONCRETE GUARD-RAIL MAKING METHOD, THE SRC GUARD-RAIL, CONSTRUCTION METHOD THEREWITH
Base Plate Assembly of Street Light
COMPRESSIBLE CONTAINER
LEVELLING MOUNTING BRACKET
LID
VACUUM CLEANER
CARAFE LID
CONTAINER
STEAMER
DISPLAY SCREEN
Asignación dinámica de recursos, programación y señalización para un servicio de velocidad variable de datos en evolución a largo plazo (LTE)
Máquina de bajo consumo de potencia para el moldeo por soplado de recipientes
LED封装体
电子装置;ELECTRONIC DEVICE